Invizyne technologies announces closing of initial public offering

Monrovia, ca, nov. 14, 2024 (globe newswire) -- invizyne technologies, inc. , a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the closing of its initial public offering of 1,875,000 shares of its common stock at a public offering price of $8.00 per share. the shares began trading on nasdaq under the ticker symbol “iztc” on november 13, 2024.
MDBH Ratings Summary
MDBH Quant Ranking